C0614

(±) Clopidogrel hydrogensulfate

≥98% (HPLC), powder

• Synonym(e): Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate, SR-25990
• Empirische Formel (Hill-System): C₁₆H₁₆ClNO₂S · H₂SO₄
• CAS-Nummer: 135046-48-9
• Molekulargewicht: 419.90
• MDL-Nummer: MFCD05865229
• UNSPSC-Code: 51111800
• PubChem Substanz-ID: 329774806
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Lagerbedingungen: desiccated
• Farbe: white
• Löslichkeit: DMSO: ~26 mg/mL
• Ersteller: Bristol-Myers Squibb
• Lagertemp.: 2-8°C
• SMILES String: OS(O)(=O)=O.COC(=O)C(N1CCc2sccc2C1)c3ccccc3Cl
• InChI: 1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)
• InChIKey: FDEODCTUSIWGLK-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

Inhibits ADP-induced platelet aggregation; anti-thrombotic drug.

Leistungsmerkmale und Vorteile

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the P2 Receptors: P2Y G-Protein Family page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Verpackung

Store under desiccant

Sicherheitshinweise

• Piktogramme: GHS05,GHS09
• Signalwort: Danger
• H-Sätze: H314,H411
• P-Sätze: P260 - P273 - P280 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338
• Gefahreneinstufungen: Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B
• Lagerklassenschlüssel: 8A - Combustible corrosive hazardous materials
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)